and follow-on capital from Alphabet, its parent company and an existing investor. Isomorphic Labs described plans to use the funds to drive biomedical advances through its AI drug design engine.

Alphabet shocked investors with its plan for $75 billion in capital expenditures in 2025. Its investments are paying off with strong Google Cloud growth and improvements to search and advertising.